ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Bortezomib Followed by the Addition of Doxorubicin at Disease Progression in Treating Patients With Locally Advanced, Recurrent, or Metastatic Adenoid Cystic Carcinoma (Cancer) of the Head and Neck

This study has been completed.
Study NCT00077428.   Last updated on July 23, 2008.   Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:
1 Conditions listed in this trial
Head and Neck Cancer
2 Additional conditions recognized in this trial
Carcinoma
Carcinoma, Adenoid Cystic
Head and Neck Neoplasms
3 More general conditions related to this trial
Adenocarcinoma
Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Glandular and Epithelial
4 Interventions listed in this trial
bortezomib
doxorubicin hydrochloride
5 Additional drug interventions recognized in this trial
Doxorubicin
6 More general drug interventions related to this trial
Antibiotics, Antineoplastic
Antineoplastic Agents
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Protease Inhibitors
Therapeutic Uses
7 Sponsors listed in this trial
Eastern Cooperative Oncology Group
National Cancer Institute (NCI)
Southwest Oncology Group




Links to all studies - primarily for crawlers